Achieving : Actualité Achieving en direct - P5 | Bourse Reflex
Accueil > Tags > Achieving

  • Toutes les actualités en rapport avec « Achieving »

02/08 14:30 Achieving - Advanced Energy Announces Garry Rogerson to Join as CEO; Dr. Hans Betz to Retire

25/07 12:30 Achieving - Raptor Pharmaceutical Meets Primary Endpoint in Its Phase 3 Clinical Trial of DR Cysteamine for Nephropathic Cystinosis

21/07 18:35 Achieving - First-half 2011 revenues

07/07 20:30 Achieving - SIGNS A STRATEGIC ACQUISITION IN ITALY

30/06 08:00 Achieving - Altamir Amboise invests in Amplitude - Apax Partners acquires a majority stake in the French specialist in orthopaedic implants, from Weinberg Capital Partners

06/06 07:30 Achieving - Eurofins doubles dividends to shareholders

09/05 07:00 Achieving - Strong Q1 topline growth provides solid start to 2011

20/04 14:00 Achieving - NASDAQ OMX Reports Record First Quarter 2011 Results

19/04 15:00 Achieving - NASDAQ OMX Group and IntercontinentalExchange Deliver Proposed Merger Agreement to NYSE Euronext Board of Directors; Demonstrate Commitment to Proposal That is Superior by 21% or USD 2 Billion

12/04 18:00 Achieving - Excellent results for 2010

01/04 13:30 Achieving - NASDAQ OMX Group Inc. and IntercontinentalExchange Propose Superior Transaction to Acquire NYSE Euronext for USD 42.50 Per Share, 19% Premium to Deutsche Boerse Proposal

28/02 07:35 Achieving - Eurofins generates strong Free Cash Flows in 2010 as it begins to reap the benefits from its investments

16/02 16:40 Achieving - OPNET Application Performance Management (APM) Solutions Verified as Citrix Ready

28/01 07:00 Achieving - After strong improvement of results in Q4 2010 and completion of its investment and reorganization programmes, Eurofins reaffirms its mid-term objectives

25/01 07:45 Achieving - Strong Barrels and Closures activity: 10.5% growth in third quarter 2010-2011

24/01 12:30 Achieving - Raptor Pharmaceutical Completes Enrollment in Pivotal Phase 3 Clinical Trial of DR Cysteamine for the Potential Treatment of Nephropathic Cystinosis

20/01 17:50 Achieving - Activity 2010

22/12 09:00 Achieving - Merrion Pharmaceuticals Plc Signs Collaboration and Option Agreement and Warrant Agreement With Novo Nordisk

21/12 07:30 Achieving - Steria demonstrates leadership in carbon performance

06/12 08:00 Achieving - Merrion Pharmaceuticals Plc Signs Feasibility and Option Agreement for 3 Drugs With International 'Top Ten' Pharmaceutical Company